Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2021
Clear all
Type
Audience
Category
Issue
Last updated
- (-) 2021
- December 20215 results available
- November 20217 results available
- October 202122 results available
- September 20217 results available
- August 20216 results available
- July 202110 results available
- June 202111 results available
- May 202118 results available
- April 202112 results available
- March 20216 results available
- February 20218 results available
- January 202115 results available
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 127 items.
Health Canada is warning consumers not to use Herberex, advertised as an herbal product for sexual enhancement, because it may pose serious health risks. Herberex was authorized as a natural health product, but Health Canada testing found the product…
AlertPublic advisory | 2021-12-31
No stability data to support affected lots' shelf life.
Affected lots are labelled with the incorrect expiry date found on the container
RecallHealth product recall | 2021-12-30
No stability data to support affected lots' shelf life.
RecallHealth product recall | 2021-12-22
CellChem Pharmaceuticals Inc. is recalling all lots of cold and flu medications, sold in pouches of dissolvable powder, due to potential health risks. The products are authorized for use in adults and children 12 years of age and older. They are…
AlertPublic advisory | 2021-12-20
Presence of N-nitrosodimethylamine (NDMA) above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2021-12-03
Product sterility may be compromised in the affected lot due to the possibility of defects in the vial.
RecallHealth product recall | 2021-11-22
Blistex Corporation is recalling three lots of Odor-Eaters Spray Powder (D20C04, D20K13 and D21H03) due to contamination with benzene. Frequent and long-term exposure (e.g., through the skin or by inhalation) to elevated levels of benzene may pose…
AlertPublic advisory | 2021-11-19
Affected lots may contain the presence of benzene contamination.
RecallHealth product recall | 2021-11-19
Data integrity concerns with product's bioequivalence data.
RecallHealth product recall | 2021-11-16
Out of Specification result, potential for presence of particulate matter in this lot.
RecallHealth product recall | 2021-11-15
The impurities are out of specification in the affected lots.
RecallHealth product recall | 2021-11-09
The impurities are out of specification in the affected lots.
RecallHealth product recall | 2021-11-09
Presence of impurity N-methyl-N-nitroso-2-[(2-methylphenyl)phenylmethoxy]ethanamine (NMOA) above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2021-10-27
Multiple lots of irbesartan, losartan and valsartan drugs recalled
Starting date:
May 30, 2021
Posting date:
October 26, 2021
Type of communication:
Advisory
Subcategory:…
AlertPublic advisory | 2021-10-26
Presence of impurity Losartan Azide ((5-(4'-((5-(azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1'-biphenyl]-2-yl)-1H-tetrazole)) above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2021-10-25